Integra LifeSciences Holdings Corporation (IART) vs Replimune Group, Inc. (REPL)

A side-by-side comparison of Integra LifeSciences Holdings Corporation and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IART vs REPL

growth of $100 · dividends reinvested · last 8y
IART -79.0% (-17.7%/yr)REPL -13.3% (-1.8%/yr)REPL compounded faster over this window
0100200300Start $1002020202220242026$21$87
IART REPL

IART vs REPL: by the numbers

  • •REPL is the larger company ($1.10B vs $1.03B market cap).
  • •Both run net losses; REPL's is the smaller (0.00% vs -0.44% net margin).

Metrics side by side

Valuation

MetricIARTREPL
Forward P/E5.44N/A
P/S ratio0.63N/A
P/B ratio0.9810.40
EV / EBITDA3.53N/A

Profitability

MetricIARTREPL
Gross margin53.74%0.00%
Operating margin4.18%0.00%
Net margin-0.44%0.00%
ROE-0.69%-281.14%
ROIC20.01%-139.11%

Growth (annualized)

MetricIARTREPL
Revenue CAGR (5Y)1.77%N/A
Total return CAGR (5Y)-28.16%-15.17%

Frequently asked

How have IART and REPL total returns compared?
Over the past 5 years, IART delivered -28.16% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.